Thalassemia Major: Clinical Trials

4 trials for Thalassemia Major, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 unknown. 4 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Completed 3, Unknown 1
Phase 23Completed 2, Unknown 1

Follow Thalassemia Major: new trials by email Literature Review of Thalassemia Major trials Research Report on Thalassemia Major

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hydroxy Urea, Omega 3, Nigella Sativa,Honey on Oxidative Stress and Iron Chelation in Pediatric Major Thalassemia
Omega 3, Nigella Sativa Oil, Hydroxyurea - Iron Overload, Oxidative Stress
Phase 2 / Phase 3CompletedBeni-Suef University3502019-11-012021-01-27
Role of Vitamin C to Augment Iron Chelation With DFP or DFX
Vitamin C, Defriprone, deferisarox, deferiprone , deferesarox - Vitamin c, Thalassemia Major
Phase 2 / Phase 3UnknownAin Shams University502014-04-012014-03-11
Study to Evaluate Efficacy and Safety of S303 Treated Red Blood Cells (RBCs)in Subjects With Thalassemia Major Requiring Chronic RBC Transfusion
S-303 Treated Red Blood Cells (RBCs), Conventional, untreated Red Blood Cells - Thalassemia Major
Phase 3CompletedCerus Corporation862012-12-012018-07-18
Amlodipine Use in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major
Amlodipine - Thalassemia Major
Phase 2 / Phase 3CompletedUniversity of Campinas, Brazil102008-09-012015-01-05

Narrower conditions

beta-Thalassemia (4)  ·  Iron Overload (1)

Broader conditions

Anemia (4)  ·  Anemia, Hemolytic (4)  ·  Anemia, Hemolytic, Congenital (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Genetic Diseases, Inborn (4)  ·  Hematologic Diseases (4)  ·  Hemic and Lymphatic Diseases (4)  ·  Hemoglobinopathies (4)  ·  Thalassemia (4)  ·  Iron Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Amlodipine (1)  ·  Ascorbic Acid (1)  ·  Congresses as Topic (1)  ·  Deferiprone (1)  ·  Deferoxamine (1)  ·  Docosahexaenoic Acids (1)  ·  Honey (1)  ·  Hydroxyurea (1)  ·  Isoflurophate (1)  ·  Nigella sativa oil (1)

Sponsors

Ain Shams University (1)  ·  Beni-Suef University (1)  ·  Cerus Corporation (1)  ·  University of Campinas, Brazil (1)

Countries

Egypt (2)  ·  Brazil (1)  ·  Italy (1)  ·  Saudi Arabia (1)  ·  Turkey (Türkiye) (1)

Top investigators

Ahmed F Mahmoud Hussein, MS.c (1)  ·  Antonio Piga, MD (1)  ·  Juliano L Fernandes, MD (1)  ·  Raffaella Origa, MD (1)  ·  Yesim Aydinok, MD (1)

Results publications

PMID 37975597